Stockscreener 앱 받기
0.21%
Amgen Inc 주식(AMGN)의 최신 뉴스
Amgen Inc. (NASDAQ:AMGN) Stock Position Lifted by Raymond James Financial Inc. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Philadelphia Trust Co. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Brandywine Global Investment Management LLC - MarketBeat
GKV Capital Management Co. Inc. Sells 10,745 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Boston Partners - MarketBeat
Sienna Gestion Decreases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Lowers Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Rathbones Group PLC - MarketBeat
Amgen FY2026 EPS Forecast Increased by Cantor Fitzgerald - MarketBeat
American Investment Services Inc. Acquires 3,378 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Nations Financial Group Inc. IA ADV Reduces Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
State of New Jersey Common Pension Fund D Reduces Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by EverSource Wealth Advisors LLC - MarketBeat
Sector Gamma AS Purchases 13,000 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Can Amgen Inc. continue delivering strong returnsMarket Sentiment Report & Free Community Consensus Stock Picks - thegnnews.com
Prudential PLC Decreases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Gulf International Bank UK Ltd - MarketBeat
Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com
Russell Investments Group Ltd. Reduces Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
AIA Group Ltd Purchases Shares of 1,413 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Greenlight Capital Announces Q2 2025 Trades: New Positions in FLR and VSCO, Exit From VTRS - Benzinga
Cantor Fitzgerald Increases Earnings Estimates for Amgen - MarketBeat
Waypoint Wealth Partners Inc. Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sei Investments Co. Raises Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen’s KRAS Mutation Study: A Potential Game-Changer in Colorectal Cancer Treatment - MSN
Amgen’s Evolocumab Study Completes: A New Era in Cardiovascular Prevention? - MSN
Amgen’s Promising Phase 2 Asthma Study: What Investors Need to Know - MSN
Amgen’s Sotorasib Study Update: Expanded Access for NSCLC Patients - MSN
Public Sector Pension Investment Board Purchases 5,732 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Stock Analysis | Amgen OutlookA Neutral Technical Picture Amid Mixed Analyst Ratings and Positive Fund Flows - AInvest
Resona Asset Management Co. Ltd. Buys 13,390 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Financial Engines Advisors L.L.C. Reduces Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Q2 2025 Earnings Call Transcript - MSN
Amgen shares rise 1.80% intraday after Daiwa Securities adjusts price target to $310. - AInvest
Judge overturns Amgen’s $50m damages loss - Life Sciences Intellectual Property Review
Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet - Yahoo Finance
Amgen price trapped in a hesitant placeForecast today15-08-2025 - Economies.com
Neuberger Berman Group LLC Sells 12,327 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Daiwa Securities Adjusts Price Target on Amgen to $310 From $350, Maintains Outperform Rating - MarketScreener
Analyst recommendations: Amgen, Applied Materials, Cisco, Nvidia, Oracle… - MarketScreener
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Cobblestone Capital Advisors LLC NY - MarketBeat
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Judge Says Patents In $50M Amgen Jury Loss Unenforceable - Law360
Amgen Legal Victory Overturns Patent Ruling Boosts Stock Ranks 177th in Trading Volume - AInvest
Aveo Capital Partners LLC Sells 1,157 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Beats $50 Million Blincyto Verdict in Lindis Patent Case - Bloomberg Law News
Independent Advisor Alliance Increases Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Ligand Announces Closing of Convertible Senior Notes Offering - GlobeNewswire Inc.
US judge overturns Amgen's $50.3 mln loss in cancer drug patent case - Reuters
American Alpha Advisors LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Back To Basics: Why I Favor Amgen Over Johnson & Johnson (NYSE:JNJ) - Seeking Alpha
Amgen’s Rocatinlimab Study: A Potential Game-Changer for Atopic Dermatitis - TipRanks
Amgen’s Long-term Study on Dazodalibep: A Potential Game-Changer for Sjögren’s Syndrome - TipRanks
Amgen and AstraZeneca’s New Study on Tarlatamab for Lung Cancer: Key Insights for Investors - TipRanks
Amgen’s Romiplostim Study: A Potential Breakthrough in Cancer Treatment - TipRanks
Amgen’s Phase 2 Study of AMG 193: A Potential Game-Changer in NSCLC Treatment - TipRanks
Amgen’s Pediatric Psoriasis Study: A New Frontier in Treatment - TipRanks
Amgen’s Promising Cardiovascular Study: A Potential Game Changer? - TipRanks
Amgen’s Promising Phase 3 Study on Maridebart Cafraglutide for Diabetes and Obesity - TipRanks
Amgen’s Promising Melanoma Study: A Potential Game-Changer in Cancer Treatment - TipRanks
Amgen’s Promising Weight Loss Study: A Potential Game-Changer? - TipRanks
Amgen’s Latest Clinical Trial: A Potential Game-Changer in Lung Cancer Treatment - TipRanks
Amgen’s New Study: A Potential Game-Changer in Multiple Sclerosis Treatment - TipRanks
Amgen’s Phase 3 Study on Rocatinlimab: A Potential Game-Changer for Prurigo Nodularis - TipRanks
Amgen’s Latest Study: A Potential Game-Changer in Lung Cancer Treatment - TipRanks
0.48%
0.08%
자본화:
|
볼륨(24시간):